PPIDT00380
Drug Information
| Name | Besilesomab |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB13979 |
| Type | biotech |
| Indication | Besilesomab is radiolabelled with sodium pertechnetate (Tc99m) solution to develop technetium (Tc99m) besilesomab solution. This solution is indicated in adults for scintigraphic imaging - in conjunction with other appropriate imaging modalities, when possible - in determining the location of inflammation/infection in peripheral bone in adults with suspected osteomyelitis [FDA Label]. When utilized as such, this medicinal product is for diagnostic use only [FDA Label]. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, for solution | Intravenous |
1 MG
|
| Kit | Intravenous |
1 mg
|